Adaptation And Attenuation Of Very Virulent Infectious Bursal Disease Virus In Avian And Mammalian Cell Cultures For Vaccine Development by Khor, Sok Fang
  
 
UNIVERSITI PUTRA MALAYSIA 
 
 
 
ADAPTATION AND ATTENUATION OF VERY VIRULENT  
INFECTIOUS BURSAL DISEASE VIRUS IN AVIAN AND MAMMALIAN  
CELL CULTURES FOR VACCINE DEVELOPMENT  
 
 
 
 
 
 
 
 
 
 
 
 
KHOR SOK FANG  
 
 
FPV 2007 12 
 
 
 
 
ADAPTATION AND ATTENUATION OF VERY VIRULENT 
INFECTIOUS BURSAL DISEASE VIRUS IN AVIAN AND MAMMALIAN 
CELL CULTURES FOR VACCINE DEVELOPMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KHOR SOK FANG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MASTER OF SCIENCE 
UNIVERSITI PUTRA MALAYSIA 
 
2007 
ADAPTATION AND ATTENUATION OF VERY VIRULENT 
INFECTIOUS BURSAL DISEASE VIRUS IN AVIAN AND MAMMALIAN 
CELL CULTURES FOR VACCINE DEVELOPMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KHOR SOK FANG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis Submitted to the School of Graduate Studies,  
Universiti Putra Malaysia, in Fulfilment of the Requirements for the 
Degree of Master of Science  
 
June 2007
  
 
 
Dedicated with love and gratitude to 
 
 
 
 my family, teachers and friends  
 
who  
 
show me the fun of education. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
  
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in 
fulfilment of the requirement for the degree of Master of Science. 
 
ADAPTATION AND ATTENUATION OF VERY VIRULENT INFECTIOUS 
BURSAL DISEASE VIRUS IN AVIAN AND MAMMALIAN CELL 
CULTURES FOR VACCINE DEVELOPMENT 
 
By 
 
KHOR SOK FANG 
 
June 2007 
 
 
Chairman : Mohd. Hair Bejo, PhD 
 
Faculty : Veterinary Medicine 
 
 
Infectious bursal disease virus (IBDV) is an immunosuppressive virus 
causing infectious bursal disease (IBD) outbreaks since 1957. The 
economic impact of IBD is influenced by strain of virus, route of infection, 
intercurrent primary and secondary pathogens, and environmental 
management factors. Adaptation of IBDV to replicate in cell culture is 
associated with attenuation. Repeated passages of classical IBDV (cv 
IBDV) in avian primary cell culture, results in highly attenuated virus, 
which is commonly used as a live vaccine for many years. However, this 
cvIBDV vaccine does not provide full protection against very virulent 
IBDV (vvIBDV) infection. Field isolates particularly vvIBDV normally do 
not grow in cell cultures. It requires extensive passages and adaptation 
in chicken embryonated eggs before it can propagate in cell cultures.  
 
This study attempts to adapt and attenuate two local isolates of vvIBDV 
namely B0081 and UPM93273 in mammalian continuous cell line (Vero 
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 cell cultures) and avian primary cell line (Chicken embryo fibroblast, 
(CEF)). A newly modified method of adaptation and attenuation is 
introduced in this study. Both isolates were successfully adapted and 
attenuated in Vero cell cultures of 22 passages throughout the proposed 
modified method. Furthermore, through the modified method, both 
isolates can be adapted and propagated faster and easier in mammalian 
continuous cell cultures when compared with the conventional method. 
Passage 10 of isolate B0081 in Vero cell cultures using modified method, 
called B0081T was tested for pathogenicity in specific pathogen free 
(SPF) chickens. This study showed that UPM0081T caused sudden 
onset of 100% morbidity with no mortality during infection and the 
infected bursal recovered from the infection. 
 
Sequence comparison has also been carried out for nucleotides (nt) and 
deduced amino acids (aa) in hypervariable region (HVR) of VP2 of 
UPM0081T with the parental isolate B0081 in this study. As a result, the 
parental isolate B0081 revealed one mutation from G to A in UPM0081T at 
nucleotide position 850. This nucleotide substitution resulted in the 
substitution of Ala in the parental virus to Thr in the cell culture attenuated 
strains at residue 284. Amino acid residues Gln, Asp and Ala at position 253, 
279 and 284 were conserved in most strains of high pathogenicity; and His, 
Asn and Thr were conserved in most of the cell culture attenuated strains of 
low pathogenicity in SPF chickens. The sequence of hypervariable region of 
VP2 of UPM0081T was deposited in GeneBank under accession number 
EF208038.  
iv 
 In conclusion, IBDV B0081 was successfully adapted and propagated in 
mammalian continuous cell cultures by the proposed modified method. The 
adapted virus was named UPM0081T. It may serve as a seed virus in the 
production of local vaccine against vvIBDV infections, for the prevention and 
control of IBD in Malaysia.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia 
sebagai memenuhi keperluan untuk Ijazah Master Sains. 
 
PENYESUAIAN DAN PELEMAHAN  VIRUS PENYAKIT BURSA 
BERJANGKIT JENIS AMAT VIRULEN DALAM TITISAN SEL  MAMALIA 
DAN UNGGAS UNTUK PERKEMBANGAN VAKSIN 
 
Oleh 
 
KHOR SOK FANG 
 
Jun 2007 
 
Pengerusi : Mohd Hair-Bejo, PhD 
 
Fakulti : Perubatan Veterinar 
 
 
Virus penyakit bursa berjangkit (IBDV) ialah virus yang boleh melemahkan 
imun dan menyebabkan wabak penyakit infeksi bursa (IBD) sejak tahun 1957. 
Kesan ekonomi oleh IBD dipengaruhi oleh jenis virus, cara infeksi, patogen 
asas dan  kedua, dan juga faktor pengurusan alam sekitar. Penyesuain IBDV 
untuk membiak dalam sel kultur sering kali dikaitkan dengan pelemahan. 
Ulangan pemindahan IBDV jenis klasik (cvIBDV) dalam sel kultur ayam asas, 
dimana pelemahannya tinggi biasanya diguna sebagai vaksin hidup sejak 
lama lagi. Walaubagaimanapun, vaksin daripada cvIBDV tidak dapat 
menyediakan perlindungan ayam sepenuhnya daripada infeksi IBDV amat 
virulen (vvIBDV). Tambahan pula, asingan liar terutamanya vvIBDV biasanya 
tidak dapat tumbuh dalam sel kultur. Ia memerlukan pemindahan yang 
panjang dan penyesuaian dalam embrio ayam sebelum dapat membiak 
dalam sel kultur terutamanya sel kultur berurutan.  
 
Kajian ini cuba untuk menyesuaikan dan melemahkan dua asingan tempatan 
vvIBDV yang dinamakan UPM93273 dan  B0081 dalam sel jenis berurutan 
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 mamalia monyet hijau Afrika (Vero sel kultur) dan sel jenis fibroblas embrio 
(embrio fibroblas ayam, CEF). Satu cara ubahsuai untuk penyesuaian dan 
melemahkan virus telah dicadangkan dalam kajian ini. Kedua-dua asingan 
berjaya disesuai dan dilemahkan dalam Vero sel kultur selama 22 pasage 
dengan menggunakan cara ubahsuai. Tambahan pula, dengan cara 
ubahsuai ini, kedua-dua asingan boleh sesuai dan tumbuh dengan lebih 
cepat dan senang dalam titisan sel berurutan mamalia bila dibanding dengan 
cara rutin. Pasage 10 untuk B0081 dalam Vero sel kultur menggunakan cara 
ubahsuai dinamakan UPM0081T telah diuji patogenisinya dalam ayam 
spesifik pathogen bebas (SPF). Keputusannya menunjukkan bahawa 
UPM0081T menyebabkan 100% morbiditi tanpa kematian semasa infeksi 
dalam ayam, dan bursa yang berinfeksi sembuh daripada jangkitan. Selain 
daripada ini, perbandingan rangkaian untuk nukleotida (nt) dan asid amino 
(aa) dalam bahagian variabel tinggi (HVR) protein virus 2 (VP2) UPM0081T 
dengan virus induk B0081 telah dijalankan. Keputusannya, virus induk telah 
menunjukkan satu penggantian dari G ke A dalam UPM0081T pada 
kedudukan 850. Penukaran nt ini menyebabkan penggantian aa Ala dalam 
virus induk kepada Thr dalam virus penyesuaian sel kultur, UPM0081T. Asid 
amino Gln, Asp dan Ala pada kedudukan 253, 279 dan 284 sememangnya 
kekal dalam kebanyakan strain penyesuaian sel kultur yang patogenesinya 
rendah pada ayam SPF. Rangkaian nukleotida dan asid amino dalam 
bahagian melampau berubah protein virus 2 untuk UPM0081T telah 
disimpan dan dipamerkan dalam GeneBank dengan nombor perolehan 
EF208038. 
 
vii 
 Kesimpulannya, IBDV B0081 telah berjaya disesuaikan dan membiak 
sebagai strain lemah UPM0081T dalam sel jenis berurutan mamalia dengan 
menggunakan cara ubah suai. Strain lemah ini mungkin boleh digunakan 
sebagai benih vaksin tempatan menentang infeksi vvIBDV di Malaysia pada 
masa depan.   
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 CHAPTER 1 
 
 
INTRODUCTION 
 
 
Infectious bursal disease (IBD) is caused by a birnavirus, infectious 
bursal disease virus (IBDV). IBD was first described by Cosgrove (1962). 
The first outbreak of the disease in 1957 was occurred around Gumboro, 
Delaware. Since then, the name Gumboro disease was used extensively 
in the past. However, clinical outbreak of the disease due to very virulent 
IBDV (vvIBDV) was only reported in Malaysia in 1991 (Hair-Bejo, 1992a; 
Loganathan et al., 1992). Infectious bursal disease is endemic in most 
poultry producing areas of the world, widespread in commercial chicken. 
The acute stage of the disease, the immunosuppression that follows, and 
the widespread distribution of the disease, are the major factors 
contributing to the economic significance. The virus is ubiquitous and 
under natural conditions, chickens acquire infection by the oral route. 
 
The bursa of Fabricius is the primary site of virus replication, but lesions 
are also detected in the spleen, thymus, cecal tonsils and Harderian 
gland. The outcome of infection depends on the age of the bird and the 
virulence of the infecting strain. Infectious bursal disease can cause high 
mortality in young, susceptible chicks but in older birds effects are 
usually mild unless complicated by secondary bacterial or other viral 
infections. The acute phase of the disease lasts for about 7-10 days.  
  
 Within this phase, bursa follicles are depleted of B cells and the bursa 
becomes atrophic.  
 
Infection with IBDV often results in immunosuppression. Allan et al. 
(1972) first reported the immunosuppressive nature of IBDV. The 
immunosuppressive effects appear to be more pronounced if virus 
exposure occurs within the first 2-3 weeks after hatched. The degree of 
immunosuppression varies depending on the virulence of the virus and, 
when the infection occurs. Immunosuppression may accompany overt 
clinical or subclinical outbreaks of IBD. The humoral immune response is 
clearly depressed, but a transient depression occurs in the cellular 
immune response (Confer et al., 1981).   
 
IBDV is a member of the genus Avibirnavirus in the family Birnaviridae, 
member of this family contain a genome consists of two segments of 
double-stranded RNA (dsRNA), designated A and B (Dobos et al., 
1979b; Muller et al., 1979b), with icosahedral symmetry and a diameter 
of about 50 to 55nm (Leong et al., 2000). The virus has five proteins 
recognized as VP1, VP2, VP3, VP4 and VP5. The smaller RNA segment 
known as segment B of the genome, with a length of about 2.8kb, 
encodes for VP1, which is a 90-kD multifunctional protein with 
polymerase and capping enzyme activities (Spies et al., 1987; Kibenge 
and Dhama, 1997). The larger segment A with a length of about 3.2kb, 
encodes for VP2, VP3, VP4 and VP5. The VP2 and VP3 are the major 
proteins of the virion constituting 51% and 40%, respectively of the total 
2 
 proteins and contain the major neutralizing epitopes. The VP2 has the 
serotype specific epitope and VP3 has a group specific antigen. VP4 is a 
minor protein involved in the processing of the precursor polyprotein 
(Birghan et al., 2000). 
 
There are two recognized serotypes of IBDV, designated 1 and 2. 
Viruses of both serotypes naturally infect chickens and turkeys, but the 
disease is recognized only in chickens and only serotype 1 viruses are 
pathogenic. Chicken is the only avian species to be susceptible to clinical 
disease and characteristic lesions caused by IBDV. It occurs as clinical 
or subclinical IBDV infection. According to antigenic variation and 
virulence, serotype 1 strains can be divided into several groups: 
classical, variant and very virulent strains (Winterfield and Thacker, 
1978). Classical strains can cause mortality (<20%) and bursal lesions. It 
is able to break through a moderate level of maternal derived antibody. 
Variant strains do not express certain virus (neutralisation) epitopes 
typical for classical strains. It is able to break through higher levels of 
maternal derived antibody than classical strains causing an early IBDV 
infection with severe bursal damage (atrophy), resulting in 
immunosuppression, and, the mortality rate is less than 5%. Very virulent 
strains of IBDV emerged in Europe in the late eighties and spread 
throughout the world causing substantial economic losses.  Very virulent 
strains are characterized by their ability to break through high level of 
maternally derived antibodies and to induce mortality more than 20%.  
 
3 
